Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05294640 · ClinicalTrials.gov registry record · Phase 4
Bacteriostatic Saline as a Local Anesthetic in Minor Eyelid Procedures
A Phase 4 study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 4
- Development phase
- 95
- Enrollment target
NCT05294640 is a Phase 4 study that has completed, run by University of California, San Francisco. The registered enrollment target is 95 participants.
The verdict
NCT05294640, a Phase 4 study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 95 participants
- Enrollment target
Study Summary
The investigators aim to assess whether bacteriostatic saline provides the same level of anesthesia as traditional local anesthesia while reducing pain associated with medication infusion in minor eyelid procedures
Interventions
- DRUG 0.9% Bacteriostatic Local Anesthetic Injection
- DRUG 1% Lidocaine with 1:100,000 epinephrine Local Anesthetic Injection
- PROCEDURE Eyelid Lesion Removal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2022-05-17 |
| Est. Completion | 2023-02-21 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05294640
The ClinicalTrials.gov registry entry for NCT05294640 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 95 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which 0.9% Bacteriostatic Local Anesthetic Injection is the first listed.
NCT05294640 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05294640 about?
NCT05294640 is a clinical study titled "Bacteriostatic Saline as a Local Anesthetic in Minor Eyelid Procedures". The investigators aim to assess whether bacteriostatic saline provides the same level of anesthesia as traditional local anesthesia while reducing pain associated with medication infusion in minor eyelid procedures
What is the current status of trial NCT05294640?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 95 participants. The study started on 2022-05-17. Estimated completion is 2023-02-21.
What interventions are being tested in trial NCT05294640?
The interventions under investigation include: 0.9% Bacteriostatic Local Anesthetic Injection (DRUG), 1% Lidocaine with 1:100,000 epinephrine Local Anesthetic Injection (DRUG), Eyelid Lesion Removal (PROCEDURE).
Who is sponsoring clinical trial NCT05294640?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.